Vogt-Koyanagi-Harada Syndrome Induced by Pembrolizumab in a Patient with Non–Small Cell Lung Cancer

Journal of Thoracic Oncology

Volumn 13, Issue 10, 2018, Pages 1606-1607

  Tamura, Tomoki ^a   Akimoto, Etsuko ^a   Matsumoto, Chiaki ^a   Mori, Syunta ^a   Nishi, Tatuya ^a   Kudo, Kennichiro ^a   Kuyama, Syouichi ^a  

^a IWAKUNI NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; PEMBROLIZUMAB; PROGRAMMED DEATH 1 LIGAND 1; IMMUNOLOGICAL ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY;

ADRENAL DISEASE; ADULT; ADVANCED CANCER; ARTICLE; ASEPTIC MENINGITIS; BACKACHE; CANCER PATIENT; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; EYE PAIN; HEARING IMPAIRMENT; HEMOPTYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JAPANESE (PEOPLE); LUNG BIOPSY; LYMPHADENOPATHY; MALE; MEDIASTINUM LYMPH NODE; MIDDLE AGED; MULTIPLE CYCLE TREATMENT; NON SMALL CELL LUNG CANCER; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SMOKING; UVEITIS; VOGT KOYANAGI SYNDROME; CHEMICALLY INDUCED; COMPLICATION; LUNG TUMOR; MENINGOENCEPHALITIS; PATHOLOGY;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 85049916401     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2018.04.026     Document Type: Article

References (5)

1. Reck, M., Rodríguez-Abreu, D., Robinson, A.G., et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 375 (2016), 1823–1833.
2. Ribas, A., Hamid, O., Daud, A., et al. Association of pembrolizumab with tumor response and survival among patients with advanced melanoma. JAMA 315 (2016), 1600–1609.
3. Bricout, M., Petre, A., Amini-Adle, M., et al. Vogt-Koyanagi-Harada-like syndrome complicating pembrolizumab treatment for metastatic melanoma. J Immunother 40 (2017), 77–82.
4. Crosson, J.N., Laird, P.W., Debiec, M., Bergstrom, C.S., Lawson, D.H., Yeh, S., Vogt-Koyanagi-Harada-like syndrome after CTLA-4 inhibition with ipilimumab for metastatic melanoma. J Immunother 38 (2015), 80–84.
5. Abdel-Rahman, O., Oweira, H., Petrausch, U., et al. Immune-related ocular toxicities in solid tumor patients treated with immune checkpoint inhibitors: a systematic review. Expert Rev Anticancer Ther 17 (2017), 387–394.